[(111)In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial

INTRODUCTION: Medullary thyroid cancer (MTC) is a rare malignant tumour of the parafollicular C-cells with an unpredictable clinical course and currently suboptimal diagnostic and therapeutic options, in particular in advanced disease. Overexpression of cholecystokinin-2 receptors (CCK2R) represents...

Descripción completa

Detalles Bibliográficos
Autores principales: Lezaic, Luka, Erba, Paola Anna, Decristoforo, Clemens, Zaletel, Katja, Mikolajczak, Renata, Maecke, Helmut, Maina, Theodosia, Konijnenberg, Mark, Kolenc, Petra, Trofimiuk-Müldner, Malgorzata, Przybylik-Mazurek, Elwira, Virgolini, Irene, de Jong, Marion, Fröberg, Alide C, Rangger, Christine, Di Santo, Gianpaolo, Skorkiewicz, Konrad, Garnuszek, Piotr, Solnica, Bogdan, Nock, Berthold A., Fedak, Danuta, Gaweda, Paulina, Hubalewska-Dydejczyk, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852173/
https://www.ncbi.nlm.nih.gov/pubmed/36334104
http://dx.doi.org/10.1007/s00259-022-05992-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852173/
https://www.ncbi.nlm.nih.gov/pubmed/36334104
http://dx.doi.org/10.1007/s00259-022-05992-6

Ejemplares similares